| pubmed-article:15767644 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C1261473 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C1518932 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0013089 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0020823 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0042679 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C1317973 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0183683 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0344211 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C1521721 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15767644 | lifeskim:mentions | umls-concept:C1171411 | lld:lifeskim |
| pubmed-article:15767644 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:15767644 | pubmed:dateCreated | 2005-6-17 | lld:pubmed |
| pubmed-article:15767644 | pubmed:abstractText | To describe the response rate and survival of children and adolescents with unresected or metastatic nonrhabdomyosarcomatous soft tissue sarcomas (NRSTS) treated with vincristine, ifosfamide, and doxorubicin. | lld:pubmed |
| pubmed-article:15767644 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15767644 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15767644 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15767644 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15767644 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:PrattCharlesC | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:DevidasMeenak... | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:GrierHolcombe... | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:MarcusRobertR | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:PappoAlberto... | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:GebhardtMarkM | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:ThomasPatrick... | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:RaoBhaskarB | lld:pubmed |
| pubmed-article:15767644 | pubmed:author | pubmed-author:JenkinsJessee... | lld:pubmed |
| pubmed-article:15767644 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15767644 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:15767644 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:15767644 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15767644 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15767644 | pubmed:pagination | 4031-8 | lld:pubmed |
| pubmed-article:15767644 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:meshHeading | pubmed-meshheading:15767644... | lld:pubmed |
| pubmed-article:15767644 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15767644 | pubmed:articleTitle | Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. | lld:pubmed |
| pubmed-article:15767644 | pubmed:affiliation | The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G1X8, Canada. alberto.pappo@sickkids.ca | lld:pubmed |
| pubmed-article:15767644 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15767644 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15767644 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15767644 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15767644 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15767644 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15767644 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15767644 | lld:pubmed |
